AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IBUPROFENE+PARACETAMOL+CAFEINE
10 registrations across 2 African markets— 4 active
Markets with IBUPROFENE+PARACETAMOL+CAFEINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TRIALGIC 200MG/325MG/30MG GELULE BOITE DE 24 | 🇨🇮Côte d'Ivoire | B&O PHARM | active | Aug 2026 |
| NO-DOL PLUS 200MG/325MG/30MG COMPRIME BOITE DE 25X4 | 🇨🇮Côte d'Ivoire | PRODIPHARM | expired | Jan 2026 |
| TRIBAX 200MG/325MG/ 30MG GELULE BOITE DE 24 | 🇨🇮Côte d'Ivoire | LABORATOIRES GSS PHARMA PVT LTD | expired | Oct 2024 |
| WINIBU 325MG/200MG/30MG GELULE BOITE DE 20 | 🇨🇮Côte d'Ivoire | SK MEDICINES DMCC | expired | Oct 2024 |
| IBUMOL C 200MG/325MG/30MG GELULE BOITE DE 24 | 🇨🇮Côte d'Ivoire | AJANTA PHARMA | expired | Jan 2023 |
| COFEN 200MG/325MG/30MG COMPRIME BOITE DE 20 | 🇨🇮Côte d'Ivoire | CROIENT PHARMA PVT. LTD | expired | Jan 2023 |
| 3ALGIC 200MG/325MG/30MG COMPRIME BOITE DE 10 | 🇨🇮Côte d'Ivoire | MEDILAB UK LTD | expired | Jan 2021 |
| TRIALGIC COMPRIME / 200mg/325mg/30mg | 🇸🇳Senegal | B&O PHARMA | active | — |
| TRIALGIC COMPRIME / 200mg/325mg/30mg | 🇸🇳Senegal | B&O PHARMA | active | — |
| TRIALGIC gélule / 200 mg / 325 mg / 30 mg | 🇸🇳Senegal | B&O PHARM | active | — |
IBUPROFENE+PARACETAMOL+CAFEINE in Africa — Regulatory Overview
IBUPROFENE+PARACETAMOL+CAFEINE is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 4 (40%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.